| 产品详情 |
| Edit |   |
| Product Name | BIGH3 (Fasciclin domain 4), 502-636aa, Human, E Coli |
| Description | MW: 14.5 kDa (135 aa), confirmed by MALDI-TOF. Purity >95% by SDS-PAGE. BIGH3, also known as TGFBI and betaig-h3, is an extracellular matrix protein induced by transforming growth factor (TGF)-beta 1. BIGH3 protein is involved in cell growth, cell differentiation, wound healing and cell adhesion. In addition, some missense mutations of BIGH3 were identified in families affected with human autosomal dominant corneal dystrophies. BIGH3 gene encodes for a 683 amino-acid protein containing an RGD mo |
| Size | 0.1 mg, 0.5 mg |
| Concentration | 1 mg/ml (determined by Bradford assay) |
| Applications | SDS-PAGE |
| Other Names | [TGFBI; BIGH3; BIGH3; Fasciclin domain 4; Beta ig-h3; Kerato-epithelin; RGD-containing collagen-associated protein; RGD-CAP; Transforming growth factor-beta-induced protein ig-h3; RGD containing collagen associated protein; Beta ig h3; AI747162; big h3; CSD3; Kerato epithelin; LCD1; MGC150270; RGD CAP; TGFBI transforming growth factor; beta induced; 68kDa; AI181842; Beta ig; CDB1; CDG2; CDGG1; CSD; CSD1; CSD2; EBMD; Transforming growth factor beta induced protein ig h3.] |
| Gene, Accession, CAS # | BIGH3, Gene ID: 7045, Accession: NP_000349 |
| Catalog # | MBS203065 |
| Price | |
| Order / More Info | BIGH3 (Fasciclin domain 4), 502-636aa, Human, E Coli from MYBIOSOURCE INC. |
| Product Specific References | Billings PC, et al. (2002). J Biol Chem. 277. 28003-28009; Munier FL. et al. (2002). Invest Ophthalmol Vis Sci. 43.949-954.; Jung-Eun Kim, et al. (2000) J Biol Chem. 275. 30907-30915; |
| 产品资料 |
|
|